VI-60 is a dual, orally active inhibitor of cPLA 2 and COX-2 , which reveals an anti-inflammtory efficacy through the inhibition of p38 MAPK/cPLA 2 /COX-2/PGE 2 pathway.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > COX | Products > Signaling Pathways > Phospholipase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.